Measuring treatment response to advance precision medicine for multiple sclerosis

QR Code

Measuring treatment response to advance precision medicine for multiple sclerosis

Abstract Objective To assess the independent contributions of clinical measures (relapses, Expanded Disability Status Scale [EDSS] scores, and neuroperformance measures) and nonclinical measures (new brain magnetic resonance imaging [MRI] activity and serum neurofilament light chain [sNfL] levels) f...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Peter A. Calabresi, Ludwig Kappos, Gavin Giovannoni, Tatiana Plavina, Irene Koulinska, Michael R. Edwards, Bernd Kieseier, Carl deMoor, Elias S. Sotirchos, Elizabeth Fisher, Richard A. Rudick, Alfred Sandrock
Format:	article
Langue:	EN
Publié:	Wiley 2021
Sujets:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Accès en ligne:	https://doaj.org/article/fa352fd8745148f48a725597ae0f7a77
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Critical appraisal of the role of fingolimod in the treatment of multiple sclerosis
par: Warnke C, et autres
Publié: (2011)

Natalizumab for the treatment of relapsing multiple sclerosis
par: Richard A Rudick, et autres
Publié: (2008)

Subcutaneous cladribine to treat multiple sclerosis: experience in 208 patients
par: Kimberley Allen-Philbey, et autres
Publié: (2021)

Neuroprotection in a novel mouse model of multiple sclerosis.
par: Katie Lidster, et autres
Publié: (2013)

Cognitive dysfunction in pediatric multiple sclerosis
par: Suppiej A, et autres
Publié: (2014)

The Multiple Sclerosis Treatment Optimization Program
par: Annette Langer‐Gould, et autres
Publié: (2021)

Towards precision in defining COPD exacerbations
par: Christine R. Jenkins
Publié: (2021)

SYNTHETIC BIOLOGY MEETS PRECISION MEDICINE: DRUG REPURPOSING FOR BLOOD CANCER PRECISION MEDICINE
par: Deepak Balaji Thimiri Govindaraj Thimiri Govindaraj
Publié: (2021)

Efficacy of a short cognitive training program in patients with multiple sclerosis
par: Pérez-Martín MY, et autres
Publié: (2017)

Genomic regions associated with multiple sclerosis are active in B cells.
par: Giulio Disanto, et autres
Publié: (2012)

Precision targeting of brain networks in TBI
par: Shan Siddiqi
Publié: (2021)

Neurobehavioral burden of multiple sclerosis with nanotheranostics
par: Sriramoju B, et autres
Publié: (2015)

Role of oral teriflunomide in the management of multiple sclerosis
par: Tanasescu R, et autres
Publié: (2013)

Current and emerging treatments for amyotrophic lateral sclerosis
par: Stefano Zoccolella, et autres
Publié: (2009)

Cannabinoids in the management of spasticity associated with multiple sclerosis
par: Anna Maria Malfitano, et autres
Publié: (2008)

The role of microglia in multiple sclerosis
par: Luo C, et autres
Publié: (2017)

The use of natalizumab for multiple sclerosis
par: Brandstadter R, et autres
Publié: (2017)

Precision Medicine in Interventional Cardiology
par: Thijmen W Hokken, et autres
Publié: (2020)

Animal models of systemic sclerosis: their utility and limitations
par: Artlett CM
Publié: (2014)

Precision antiplatelet therapy for the prevention of ischaemic stroke
par: David Wang

Review of teriflunomide and its potential in the treatment of multiple sclerosis
par: Clemens Warnke, et autres
Publié: (2009)

The role of glatiramer acetate in the early treatment of multiple sclerosis
par: David W Brandes
Publié: (2010)

Association between smoking and cognitive impairment in multiple sclerosis
par: Özcan ME, et autres
Publié: (2014)

Gut microbiome is associated with multiple sclerosis activity in children
par: Mary K. Horton, et autres
Publié: (2021)

Precision oncology- the future of personalized cancer medicine?
par: Ann M. Bode, et autres
Publié: (2017)

Precision medicine: the foundation of future cancer therapeutics
par: Seung Ho Shin, et autres
Publié: (2017)

Artificial intelligence for the next generation of precision oncology
par: Pedro J. Ballester, et autres
Publié: (2021)

Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis
par: Lugaresi A, et autres
Publié: (2013)

Adherence to riluzole in patients with amyotrophic lateral sclerosis: an observational study
par: Introna A, et autres
Publié: (2018)

Cognitive status in patients with multiple sclerosis in Lanzarote
par: Pérez-Martín MY, et autres
Publié: (2016)

Prevalence of Pediatric Onset Multiple Sclerosis in Saudi Arabia
par: Reem Bunyan, et autres
Publié: (2021)

Neurophysiological changes associated with cortical lesions in multiple sclerosis.
par: Mads Alexander Just Madsen, et autres
Publié: (2021)

Impact of Andropause on Multiple Sclerosis
par: Maria C. Ysrraelit, et autres
Publié: (2021)

Imaging multiple sclerosis pathology at 160 μm isotropic resolution by human whole-brain ex vivo magnetic resonance imaging at 3 T
par: Matthias Weigel, et autres
Publié: (2021)

The hospital anxiety and depression scale, in patients with multiple sclerosis
par: Pais-Ribeiro JL, et autres
Publié: (2018)

Intractable and highly active relapsing multiple sclerosis – role of alemtuzumab
par: Dubey D, et autres
Publié: (2015)

Review of the pharmacoeconomics of early treatment of multiple sclerosis using interferon beta
par: Castrop F, et autres
Publié: (2013)

Disease-modifying therapies in relapsing&ndash;remitting multiple sclerosis
par: Fabricio Gonz&aacute;lez-Andrade, et autres
Publié: (2010)

Impact of extended-release dalfampridine on walking ability in patients with multiple sclerosis
par: Hayes KC
Publié: (2011)

T–CELL VACCINE PREPARATION FOR MULTIPLE SCLEROSIS TREATMENT
par: I. P. Ivanova, et autres
Publié: (2014)